Uncover key drivers, emerging technologies, and competitive movements shaping the workstation graphics processing unit (gpu) market from 2026–2035 with trusted insights from The Business Research Company
What level of growth is expected in the Pulmonary Drug Delivery Devices Market between 2026 and 2030?
The pulmonary drug delivery devices market has shown significant expansion in recent years. This market is anticipated to increase from $52.8 billion in 2025 to $56.49 billion in 2026, demonstrating a compound annual growth rate (CAGR) of 7.0%. The historical growth of the market can be linked to factors like the rising occurrence of respiratory diseases, an increased reliance on inhalation therapies, the expansion of programs for asthma and COPD treatment, enhancements in inhaler design technologies, and a heightened understanding of pulmonary drug delivery methods.
The pulmonary drug delivery devices market size is anticipated to experience substantial growth over the coming years, reaching $71.9 billion by 2030, with a compound annual growth rate (CAGR) of 6.2%. This projected expansion can be attributed to several factors, including the increasing demand for personalized respiratory therapies, the rising adoption of digital health integrated inhalers, the expansion of home-based respiratory care, a growing focus on non-invasive drug delivery, and continued innovation in inhalation technologies. Major trends expected during the forecast period encompass the increasing adoption of smart and connected inhaler devices, a rising demand for targeted pulmonary drug delivery, the growing use of mesh and ultrasonic nebulizers, the expansion of combination drug-device products, and an enhanced focus on patient adherence.
Access Your Free Sample Report for In-Depth Market Insights:
https://www.thebusinessresearchcompany.com/sample.aspx?id=15907&type=smp
Which Drivers Are Expected To Impact The Pulmonary Drug Delivery Devices Market During The Forecast Period?
The growing incidence of respiratory ailments is expected to drive the expansion of the pulmonary drug delivery devices market in the coming years. Respiratory disorders are defined as diseases or conditions that impact the lungs and airways, thereby affecting a person’s breathing. There is a rising prevalence of these disorders due to various contributing factors such as increasing levels of air pollution, higher smoking rates, urbanization trends, climate change, and an aging global population. Pulmonary drug delivery devices play a vital role in managing respiratory disorders by enabling the direct administration of medications to the lungs. For instance, in December 2023, a research study published by JAMA Network Open, a medical journal affiliated with the American Medical Association, projected that the global burden of chronic obstructive pulmonary disease (COPD) could lead to nearly 600 million cases worldwide by 2050, signifying a 23% increase in its prevalence. Therefore, the increasing prevalence of COPD is a key driver for the growth of the pulmonary drug delivery devices market.
Which Segments Are Driving Activity In The Pulmonary Drug Delivery Devices Market?
The pulmonary drug delivery devices market covered in this report is segmented –
1) By Product Type: Dry Powder Inhalers, Metered Dose Inhalers, Nebulizers
2) By Application: Asthma, Cystic Fibrosis, Chronic Obstructive Pulmonary Disease, Other Applications
3) By Distribution Channel: Retail Pharmacies, Hospital Pharmacies, E-Commerce
Subsegments:
1) By Dry Powder Inhalers (DPIs): Single-Dose DPIs, Multi-Dose DPIs
2) By Metered Dose Inhalers (MDIs): CFC-Based MDIs, HFA-Based MDIs
3) By Nebulizers: Jet Nebulizers, Ultrasonic Nebulizers, Mesh Nebulizers
What Industry Trends Are Transforming The Pulmonary Drug Delivery Devices Market?
Leading firms within the pulmonary drug delivery devices market are innovating products, including small-volume nebulizers, to offer enhanced features to their clientele. Specifically, a small-volume nebulizer (SVN) functions as a medical apparatus designed to administer liquid medicines as an aerosol mist to individuals suffering from respiratory ailments like asthma, chronic obstructive pulmonary disease (COPD), or cystic fibrosis. An illustration of this trend is seen in May 2024 when Medline Industries LP, a healthcare company based in the US, introduced the Hudson RCI TurboMist small-volume nebulizer. This pioneering device is engineered for swift medication delivery, completing treatments in as little as three minutes. This advanced nebulizer is capable of dispensing medication 2.5 times faster per minute than conventional models, thereby decreasing treatment durations by approximately 70%. Such an acceleration in medication administration substantially curtails treatment periods, thereby assisting healthcare providers through improved patient throughput and elevating the patient experience by shortening therapy session lengths.
Which Key Market Players Are Investing In Expansion And Innovation Within The Pulmonary Drug Delivery Devices Market?
Major companies operating in the pulmonary drug delivery devices market are Medtronic plc, Air Liquide S.A., Becton Dickinson And Company, Koninklijke Philips N.V., Medline Industries Inc., ResMed Inc., Drägerwerk AG And Co. KGaA, Smiths Group plc, AptarGroup Inc., Chiesi Farmaceutici S.p.A., Teleflex Incorporated, Fisher And Paykel Healthcare Limited, Invacare Corporation, Vyaire Medical Inc., Inogen Inc., Drive DeVilbiss Healthcare Inc., Hovione, Hamilton Medical AG, GaleMed Corporation, Allied Healthcare Products Inc., Precision Medical Inc., Salter Labs Inc.
Access The Complete Report For Deeper Market Insights:
Which Regions Are Projected To Dominate The Pulmonary Drug Delivery Devices Market In The Coming Years?
North America was the largest region in the pulmonary drug delivery devices market in 2025. The regions covered in the pulmonary drug delivery devices market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
Request Your Customized Pulmonary Drug Delivery Devices Market Research Report for Competitive Advantage:
https://www.thebusinessresearchcompany.com/customise?id=15907&type=smp
Browse Through More Reports Similar to the Global Pulmonary Drug Delivery Devices Market 2026, By The Business Research Company
Drug Delivery Devices Global Market Report 2026
https://www.thebusinessresearchcompany.com/report/drug-delivery-devices-global-market-report
Drug Delivery Devices Global Market Report 2026
https://www.thebusinessresearchcompany.com/report/drug-delivery-devices-global-market-report
Injectable Drug Delivery Devices Global Market Report 2026
Get in touch with us:
The Business Research Company: https://www.thebusinessresearchcompany.com/
Americas +1 310-496-7795
Asia +44 7882 955267 & +91 8897263534
Europe +44 7882 955267
Email us at info@tbrc.info
Follow us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company